Skip to main content
Clinical Trials/NCT02793570
NCT02793570CompletedNot Applicable

Native High-resolution 3D SSFP MR Angiography for Assessment of the Thoracic Aorta in Pregnant Subjects With Familial Aortopathies

University Hospital Birmingham NHS Foundation Trust1 site in 1 country15 target enrollmentStarted: January 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
15
Locations
1
Primary Endpoint
Gestation at delivery

Study Overview

Brief Summary

Introduction: Native magnetic resonance angiography (MRA) is recommended to assess the thoracic aorta during pregnancy, avoiding the risks of ionising radiation and contrast agent administration. This guidance is however, based only on consensus opinion supported by limited case reports (level of evidence C).

Aim: To evaluate the feasibility of performing native 3D steady-state free-precession (SSFP) MRA in pregnant subjects with inherited aortopathy to guide timing and mode of delivery.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Any pregnant subject with a history of familial aortopathy

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Gestation at delivery

Time Frame: 40 weeks

Completion of non-contrast 3D MRA aorta

Time Frame: 40 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital Birmingham NHS Foundation Trust
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

William E Moody

SpR Cardiology

University Hospital Birmingham NHS Foundation Trust

Study Sites (1)

Loading locations...

Similar Trials